Travere Therapeutics (TVTX) Free Cash Flow (2010 - 2026)
Travere Therapeutics (TVTX) free cash flow from Aug 31, 2010 to Mar 31, 2026. The TTM Travere Therapeutics (TVTX) free cash flow is $39M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Free Cash Flow
Quarterly Free Cash Flow
Annual Free Cash Flow change of Travere Therapeutics (TVTX)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2026 | -$40M | -206.86% |
| 2025 | $38M | -115.91% |
| 2024 | -$237M | -15.40% |
| 2023 | -$281M | +50.52% |
| 2022 | -$186M | +837.56% |
| 2021 | -$20M | -59.83% |
| 2020 | -$50M | -15.24% |
| 2019 | -$58M | +127.36% |
| 2018 | -$26M | -494.62% |
| 2017 | $6.51M | -555.24% |
| 2016 | -$1.43M | +7050.00% |
| 2015 | -$20K | -96.97% |
| 2014 | -$660K | -96.89% |
| 2013 | -$21M | +498.59% |
| 2012 | -$3.55M | +349.37% |
| 2011 | -$790K | N/A |
| 2010 | $0 | N/A |